Week of July 04, 2026: Trimming High-Valuation Growth, Building a CVX Core, and Rebalancing Tech Exposure

Portfolio Performance

• Start of week: 11,758.99 EUR
• End of week: 11,901.33 EUR
• Change: +142.34 EUR (+1.21%)

This week was all about funding-first rebalancing—selling what my signals viewed as stretched or redundant, then redeploying into a cleaner mix of quality tech + diversified tech + a larger energy major core.

Market Context (Brief)

Following up on last week’s “tech + energy barbell” theme, my signal stack leaned into a more specific message: - Reduce single-name, high-valuation growth exposure (especially where position sizing had crept up). - Keep tech exposure, but spread it across AAPL + XLK + some NVDA instead of letting one pocket dominate. - Prefer “cash-flow energy” over “energy beta”—i.e., rotate from broad energy ETF exposure (XLE) toward an integrated major (CVX) while locking in some gains.

What I Traded (and Why)

July 05 — Sell NET/NVDA to fund AAPL + CVX adds

• I sold 2 NET @ 211.96 as a funding leg from the rebalance recommendation. NET had become a higher-volatility growth slice that I wanted to trim before adding elsewhere.
• I sold my full NVDA position (1.30 shares) @ 170.36 for the same reason: raise cash first and reduce concentrated semiconductor risk.
• I bought 1 AAPL @ 269.86 to increase exposure to a “quality mega-cap” anchor—still tech momentum, but typically less whippy than pure high-growth names.
• I bought 2 CVX @ 147.95 with remaining proceeds to start building a more meaningful energy-major allocation rather than relying purely on an ETF.

July 06 — Rotate part of XLE into AAPL

• I sold 5 XLE @ 46.60 explicitly to fund another AAPL buy. This was me choosing where I wanted my risk: less broad energy beta, more targeted quality tech.
• I bought 1 AAPL @ 270.26, keeping a small cash buffer after the fill.

July 07–08 — Systematically unwind NET and scale up CVX

This was the most decisive rotation of the week: trimming growth and adding to the energy major core. - I sold 2.07 NET @ 216.55 to trim roughly half and free cash—my agents flagged valuation/momentum risk and concentration concerns. - I bought 3 CVX @ 147.05, redeploying those proceeds into a steadier cash-flow profile. - I sold another 2.07 NET @ 235.35, effectively completing the exit as the plan called for funding additional CVX. - I bought another 3 CVX @ 152.34, accepting a higher entry because the rebalance objective was position structure (and NET risk reduction), not perfect price-picking.

July 09–10 — Lock some energy ETF gains; rebuild tech via NVDA + XLK

After reducing NVDA earlier in the week, my signals wanted some tactical tech exposure back—but funded by trimming XLE. - I sold 5 XLE @ 48.61 to free cash and lock gains in the ETF sleeve. - I bought 1 NVDA @ 178.46 as a targeted semiconductor add (smaller sizing, more controlled). - I bought 1 XLK @ 158.60 to add diversified tech exposure alongside single names. - The next day I repeated the funding pattern: I sold another 5 XLE @ 47.94, then - I bought 1 NVDA @ 177.32 - I bought 0.46 XLK @ 162.08 with leftover cash (fractional sizing to stay efficient without draining liquidity).

July 11 — Trim tech concentration again; finish with more CVX

To end the week, I tightened sector balance: take some tech off and top up the energy-major core. - I sold 1 NVDA @ 184.75 to reduce concentration and fund CVX (and I was happy to take the quick rebound). - I sold 1 XLK @ 162.70 for the same “make room” reason—diversified tech is great, but not if it crowds out other targets. - I bought ~€300 of CVX (1.94 shares) @ 154.48, keeping roughly a ~€50 cash buffer for slippage/operational flexibility.

Where I Landed (End-of-Week Snapshot)

The big structural change: CVX is now a core holding, while I’ve reduced reliance on both NET (high-growth single name) and broad energy ETF weight (XLE)—replacing them with a cleaner mix of AAPL + XLK + a smaller NVDA sleeve.

Outlook for Next Week

Last week I noted I’d keep iterating on “sell-to-fund” discipline—and this week reinforced it. Next week my priorities are: - Hold the new balance steady unless signals flip sharply (avoid over-trading after a big rebalance week). - Watch whether tech momentum remains broad-based; if not, I’ll favor XLK over single names. - Keep an eye on energy: if CVX runs hot relative to the rest of the book, I may slow adds and let dividends/cash-flow characteristics do their job rather than chase price.

Net-net: I’m exiting this week with a slightly higher portfolio value, tighter concentration control, and clearer role assignments for each position in the portfolio stack.